← Leaderboards
Benjamin Elison Gewurz
Brigham And Women'S Hospital
$12,892,911
Attributed
$15,138,853
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,138,853 · 10
By mechanism
R01$8,463,215 · 4
U01$3,376,443 · 1
P01$1,394,895 · 1
R21$984,500 · 2
K08$899,550 · 1
R13$20,250 · 1
Top collaborators
- Ethel Cesarman5 shared
- Lisa Giulino Roth4 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Frederick C. Wang$16,331,006
- Elliott D Kieff$27,601,410
- Eric C Johannsen$4,978,414
Others in their field
Top investigators on “Human Herpesvirus 4”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$73,088,996
- Kristin Ardlie · Genomics Collaborative, Inc.$51,299,015
- Constance Ann Benson · University Of California, San Diego$36,890,085
- Donald Ym Leung · University Of Colorado Denver$32,964,660
- Louis J. Picker · Oregon Health And Science University$30,431,650
- Paul M. Lieberman · Wistar Institute$25,109,269
Research focus
Human Herpesvirus 4Malignant NeoplasmsCellsB-LymphocytesNovel Therapeutic InterventionEpstein-Barr Virus LatencyClustered Regularly Interspaced Short Palindromic RepeatsS LymphomaLymphomaProgramsGenome-WideHodgkin DiseaseEpigenetic ProcessProteomicsPathway InteractionsViralOncogenicLymphoproliferative DisordersCrispr ScreenPost-TransplantEpstein-Barr Virus InfectionsInfectionCell TransformationInsight
Grant awards (36)
B cell determinants of EBV latency$827,246
U01 · FY2025 · CA
Epstein-Barr virus LMP1 mediated oncogenicity$615,982
R01 · FY2025 · CA · contact PI
Epstein-Barr Virus Driven Tonsillar Versus Peripheral B-cell One-Carbon Metabolic Network Remodeling$508,476
R01 · FY2025 · DE · contact PI
Regulation of the Epstein-Barr Virus Lytic Switch$505,743
R01 · FY2025 · AI · contact PI
Methionine and PI3K Metabolism Drive CIMP in EBV Epithelial Cancers$479,777
P01 · FY2025 · CA · contact PI
Systematic CRISPR Analysis of EBV Lymphoma Resistance Pathways to Natural Killer Cell Lysis$268,500
R21 · FY2025 · AI · contact PI
B cell determinants of EBV latency (supplement)$30,119
U01 · FY2025 · CA
B cell determinants of EBV latency$827,278
U01 · FY2024 · CA
Epstein-Barr Virus Driven Tonsillar Versus Peripheral B-cell One-Carbon Metabolic Network Remodeling$528,226
R01 · FY2024 · DE · contact PI
Regulation of the Epstein-Barr Virus Lytic Switch$505,743
R01 · FY2024 · AI · contact PI
Methionine and PI3K Metabolism Drive CIMP in EBV Epithelial Cancers$444,045
P01 · FY2024 · CA · contact PI
Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway$268,500
R21 · FY2024 · AI · contact PI
Systematic CRISPR Analysis of EBV Lymphoma Resistance Pathways to Natural Killer Cell Lysis$223,750
R21 · FY2024 · AI · contact PI
Epstein-Barr Virus/Kaposi Sarcoma Associated Herpesvirus 2024 Meeting$20,250
R13 · FY2024 · CA · contact PI
B cell determinants of EBV latency$827,799
U01 · FY2023 · CA
Regulation of the Epstein-Barr Virus Lytic Switch$507,354
R01 · FY2023 · AI · contact PI
Methionine and PI3K Metabolism Drive CIMP in EBV Epithelial Cancers$471,073
P01 · FY2023 · CA · contact PI
Epstein-Barr virus LMP1 mediated oncogenicity$409,463
R01 · FY2023 · CA · contact PI
Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway$223,750
R21 · FY2023 · AI · contact PI
B cell determinants of EBV latency$864,001
U01 · FY2022 · CA
Regulation of the Epstein-Barr Virus Lytic Switch$507,533
R01 · FY2022 · AI · contact PI
Metabolic Network Remodeling in Epstein-Barr Virus Lymphomagenesis$447,500
R01 · FY2022 · AI · contact PI
Epstein-Barr virus LMP1 mediated oncogenicity$401,273
R01 · FY2022 · CA · contact PI
Regulation of the Epstein-Barr Virus Lytic Switch$507,533
R01 · FY2021 · AI · contact PI
Metabolic Network Remodeling in Epstein-Barr Virus Lymphomagenesis$447,500
R01 · FY2021 · AI · contact PI
Epstein-Barr virus LMP1 mediated oncogenicity$409,463
R01 · FY2021 · CA · contact PI
Metabolic Network Remodeling in Epstein-Barr Virus Lymphomagenesis$447,500
R01 · FY2020 · AI · contact PI
Epstein-Barr virus LMP1 mediated oncogenicity$409,463
R01 · FY2020 · CA · contact PI
Metabolic Network Remodeling in Epstein-Barr Virus Lymphomagenesis$447,500
R01 · FY2019 · AI · contact PI
Epstein-Barr virus LMP1 mediated oncogenicity$409,463
R01 · FY2019 · CA · contact PI
Metabolic Network Remodeling in Epstein-Barr Virus Lymphomagenesis$447,500
R01 · FY2018 · AI · contact PI
Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB$179,910
K08 · FY2014 · CA · contact PI
Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB$179,910
K08 · FY2013 · CA · contact PI
Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB$179,910
K08 · FY2012 · CA · contact PI
Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB$179,910
K08 · FY2011 · CA · contact PI
Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB$179,910
K08 · FY2010 · CA · contact PI